Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00690937 | A Multicenter, Active and Placebo-controlled Study of Enteric Coated Sevelamer in Patients With Mild to Moderate Hypercholesteremia | PHASE2 | COMPLETED | 120 | — | — | Feb 1, 2008 | Dec 1, 2008 | Mar 19, 2014 | 8 | India |
| Arm | Type | Description |
|---|---|---|
| 1 ECS | EXPERIMENTAL | Low dose treatment |
| 2 ECS | EXPERIMENTAL | High dose treatment |
| 3 Colesevelam | ACTIVE_COMPARATOR | Active control treatment |
| 4 Placebo | PLACEBO_COMPARATOR | Placebo matched to low dose treatment |
| 5 Placebo | PLACEBO_COMPARATOR | Placebo matched to high dose treatment |
| Name | Type | Description |
|---|---|---|
| Enteric coated sevelamer | DRUG | Drug treatment |
| Colesevelam Cholestagel | DRUG | Drug comparator |
| Placebo | DRUG | Placebo |
Inclusion Criteria: * Males and females 18 years of age or older * Clinical diagnosis of mild to moderate hypercholesterolemia 1)LDL cholesterol greater than or equal to 130 mg/dL and less than or equal to 220 mg/dL 2) Triglycerides less than or equal to 300 mg/dL Exclusion Criteria: * Women who ...